Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Invested Capital (2016 - 2025)

Mimedx's Invested Capital history spans 15 years, with the latest figure at $274.5 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 29.44% year-over-year to $274.5 million; the TTM value through Dec 2025 reached $274.5 million, up 29.44%, while the annual FY2025 figure was $274.5 million, 29.44% up from the prior year.
  • Invested Capital for Q4 2025 was $274.5 million at Mimedx, up from $238.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $274.5 million in Q4 2025 and bottomed at -$8.1 million in Q1 2021.
  • The 5-year median for Invested Capital is $49.3 million (2021), against an average of $109.1 million.
  • The largest annual shift saw Invested Capital crashed 107.85% in 2021 before it surged 606.83% in 2022.
  • A 5-year view of Invested Capital shows it stood at $48.2 million in 2021, then plummeted by 36.51% to $30.6 million in 2022, then soared by 369.57% to $143.7 million in 2023, then surged by 47.59% to $212.1 million in 2024, then rose by 29.44% to $274.5 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Invested Capital are $274.5 million (Q4 2025), $238.9 million (Q3 2025), and $217.9 million (Q2 2025).